SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 328,204 shares at $26.81 ($8.8M) on 2023-06-13, disclosed to the SEC on 2023-06-15.
Open-market sale of $8.8M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.81 | 36,547 | $980K | 11.2% |
| 2 | $26.81 | 36,547 | $980K | 11.2% |
| 3 | $27.23 | 70,307 | $1.9M | 21.8% |
| 4 | $27.23 | 70,307 | $1.9M | 21.8% |
| 5 | $25.92 | 20,967 | $543K | 6.2% |
| 6 | $25.92 | 20,967 |
| $543K |
| 6.2% |
| 7 | $26.24 | 36,281 | $952K | 10.8% |
| 8 | $26.24 | 36,281 | $952K | 10.8% |
| Total | $26.75 avg | 328,204 | $8.8M | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |